Language

Home/Ingredient/rituximab

rituximab

RxNorm 121191· ATC L01FA01

KR · 한국Products in Korea (11)

트룩시마주(리툭시맙)(단클론항체유전자재조합)(주)셀트리온
트룩시마주(리툭시맙)(단클론항체유전자재조합)(주)셀트리온
트룩시마주(리툭시맙)(단클론항체유전자재조합)(주)셀트리온
맙테라주(리툭시맙)(단클론항체유전자재조합)(주)한국로슈
맙테라주(리툭시맙)(단클론항체유전자재조합)(주)한국로슈
맙테라주(리툭시맙)(단클론항체유전자재조합)(주)한국로슈
맙테라피하주사(리툭시맙)(유전자재조합)(주)한국로슈
맙테라피하주사(리툭시맙)(유전자재조합)(주)한국로슈
싸이시맙주(리툭시맙)(단클론항체유전자재조합)싸이젠코리아㈜
싸이시맙주(리툭시맙)(단클론항체유전자재조합)싸이젠코리아㈜
싸이시맙주(리툭시맙)(단클론항체유전자재조합)싸이젠코리아㈜

U.S. drug label (openFDA)

Rituxan — indications, dosage, warnings, adverse events →

Not medical advice. Consult a healthcare professional. This information is general reference based on public data and does not replace consultation with a doctor or pharmacist.

Source:

U.S. National Library of Medicine — RxNorm (Public (UMLS)) [Source data]
Health Insurance Review & Assessment Service (HIRA) — Drug Master (standard drug codes) (KOGL Type 1) [Source data]
U.S. Food and Drug Administration — openFDA Drug Label (CC0) [Source data]

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

About Privacy Terms Contact

© 2026 vitalwiki. Public-data based medicine & disease information.